Načítá se...
A Review of Nitric Oxide for the Treatment of Glaucomatous Disease
Glaucoma is the leading cause of irreversible blindness worldwide, affecting 64.3 million people. An estimated 60.5 million people are affected by primary open angle glaucoma globally, and this will increase to 111.8 million by 2040. The definition of glaucoma has evolved greatly over time. Although...
Uloženo v:
| Vydáno v: | Ophthalmol Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Healthcare
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693832/ https://ncbi.nlm.nih.gov/pubmed/28584936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-017-0094-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|